Summary
Endothelin-1 (ET-1) enhanced field stimulation-evoked (0.1 Hz), nerve-mediated contractions of the prostatic portion of the rat vas deferens. The human precursor of ET-1, big-endothelin (1-38) (big-ET-1) was only two-fold less potent than ET-1 (pD2 values: 7.30 and 7.49, respectively). The threshold concentrations necessary to elicit an increase of the response to electrical stimulation was lower for ET-1 (5 nmol/l) than for big-ET-1 (25 nmol/l). Endothelin-3 (ET 3) also markedly enhanced the response of the tissue to field stimulation with a potency similar to ET-1 (pD2 value: 7.59). In contrast, the precursor of ET-3, big-endothelin (1–41) (big-ET-3), was inactive at concentrations up to 0.5 μmol/l. Treatment of the preparations with phosphoramidon (50 μmol/l) markedly reduced the twitch enhancement by big-ET-1 without affecting the response to ET-1. Our results suggest the presence of a specific phosphoramidon-sensitive endothelin-converting enzyme which converts big-ET-1 to ET-1 in the rat vas deferens.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- ECE:
-
Endothelin-converting enzyme
References
Arai H, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730–732
Bloch KD, Eddy RL, Shows TB, Quertermous T (1989) cDNA cloning and chromosomal assignement of the gene encoding endothelin-3. J Biol Chem 26:18156–18161
D'Orléans-Juste P, Lidbury PS, Warner TD, Vane JR (1990) Intravascular big-endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbit. Biochem Pharmacol 39:R21-R22
D'Orléans-Juste P, Lidbury PS, Télémaque S, Warner TD, Vane JR (1991a) Human big-endothelin releases prostacyclin in vivo and also in vitro through a phosphoramidon-sensitive conversion to endothelin-1. J Cardiovasc Pharmacol (in press)
D'Orléans-Juste P, Télémaque S, Claing A (1991b). Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro. Br J Pharmacol (in press)
Emori T, Hirata Y, Marumo F (1990) Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action. FEBS Lett 263:261–264
Fukuroda F, Noguchi K, Tsuchida S, Nishikibe M, Ikemoto F, Okada K, Yano M (1990) Inhibition of biological actions of bigendothelin-1 by phosphoramidon. Biochem Biophys Res Commun 172:390–395
Hiley CR, Pelton JT, Hiller RC (1989) Effects of endothelin on field stimulated rat vas deferens and guinea-pig ileum. Br J Pharmacol 96:104P
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863–2867
Kashiwabara T, Inagaki Y, Ohta H, Iwamatsu A, Nomizu M, Morita A, Nishikori K (1989) Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. FEBS Lett 247:73–76
Maggi CA, Guiliani S, Patacchini R, Rovero P, Giachetti A, Meli A (1989) The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur J Pharmacol 174:23–31
Matsumura Y, Hisaki K, Takaoka M, Morimoto S (1990) Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big-endothelin-1. Eur J Pharmacol 185:103–106
Rae GA, Calixto JB (1990) Effects of endothelins on nerve-mediated contractions of the mouse vas deferens. Life Sci 47:PL83-PL89
Sakurai T, Yanagisawa M, Tauwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 348:732–734
Tallarida RJ, Murray RB (1981) Manual of pharmacologic calculation with computer programs. Springer, Berlin Heidelberg New York, pp 14–19 and pp 51–52
Tousignant C, Dion S, Drapeau G, Regoli D (1987) Characterization of pre- and postjunctional receptors for neurokinins and kinins in the rat vas deferens. Neuropeptides 9:333–343
Warner TD, de Nucci G, Vane JR (1989) Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 159:325–326
Wiklund NP, Ohlén, Wiklund CU, Hedqvist P, Gustafsson LE (1990) Endothelin modulation of neuroeffector transmission in rat and guinea pig vas deferens. Eur J Pharmacol 185:25–33
Yanagisawa M, Inoue A, Ishigawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, Masaki T (1988) Primary structure, synthesis and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85:6964–6967
Author information
Authors and Affiliations
Additional information
Send offprint requests to P. D'Orléans-Juste at the above address
Rights and permissions
About this article
Cite this article
Télémaque, S., D'OrléansJuste, P. Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 344, 505–507 (1991). https://doi.org/10.1007/BF00172593
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00172593